Seeing The Strength In Synergy
Sofinnova Partners Seeds Italy’s Nascent Biotech Sector To Build New Investment Opportunities – On Both Sides Of The Atlantic
Executive Summary
In this installment of VC Playbook, profiling venture capital strategies in biopharma and medtech, In Vivo talks to Sofinnova Partners' Graziano Seghezzi about market access trends, Italy’s growing biotech offering and the perils of “health nationalism” to business partnering in the aftermath of COVID-19.